MMS provided long-term, function-preserving management of ungual melanoma in situ. MCA identified clinically meaningful subgroups suggesting potential for personalized approaches. Further multicentric validation is needed.
Reina-Román et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: